PAI-1 ELISA
BRD ID: 2029
Tier: SOP
Source: TCP Project
Number of times downloaded: 683
Description
This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical
Center (BMC) to quantify levels of plasminogen activator inhibitor-1 (PAI-1) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).
Biospecimens
FluidPlasma
Diagnoses
NeoplasticCarcinoma
Normal
Topics
Biospecimen Aliquots and Components
Platform-specific Methodology